Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Ovid Therapeutics Inc. market cap for the quarter ending 2026-08-11 was $505.82M, a 1285.25% increase year-over-year.
Ovid Therapeutics Inc. market cap for the quarter ending 2026-06-30 was $496.99M, a 2018.56% increase year-over-year.
Ovid Therapeutics Inc. market cap for the quarter ending 2026-05-08 was $522.59M, a 2434.18% increase year-over-year.
Ovid Therapeutics Inc. market cap for the quarter ending 2026-03-31 was $369.66M, a 1566.17% increase year-over-year.
Ovid Therapeutics Inc. market cap for fiscal 2026 was $505.82M.
Ovid Therapeutics Inc. market cap for fiscal 2025 was $210.9M, a 217.99% increase from fiscal 2024.
Ovid Therapeutics Inc. market cap for fiscal 2024 was $66.32M, a 70.86% decline from fiscal 2023.
Ovid Therapeutics Inc. market cap for fiscal 2023 was $227.63M, a 73.67% increase from fiscal 2022.